{"pmid":32366502,"title":"COVID-19: Coronavirus replication, pathogenesis, and therapeutic strategies.","text":["COVID-19: Coronavirus replication, pathogenesis, and therapeutic strategies.","Cleve Clin J Med","Bergmann, Cornelia C","Silverman, Robert H","32366502"],"journal":"Cleve Clin J Med","authors":["Bergmann, Cornelia C","Silverman, Robert H"],"date":"2020-05-06T11:00:00Z","year":2020,"_id":"32366502","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.3949/ccjm.87a.20047","topics":["Treatment","Mechanism"],"weight":1,"_version_":1666138496126943232,"score":9.490897,"similar":[{"pmid":31967327,"pmcid":"PMC7167049","title":"Emerging coronaviruses: Genome structure, replication, and pathogenesis.","text":["Emerging coronaviruses: Genome structure, replication, and pathogenesis.","The recent emergence of a novel coronavirus (2019-nCoV), which is causing an outbreak of unusual viral pneumonia in patients in Wuhan, a central city in China, is another warning of the risk of CoVs posed to public health. In this minireview, we provide a brief introduction of the general features of CoVs and describe diseases caused by different CoVs in humans and animals. This review will help understand the biology and potential risk of CoVs that exist in richness in wildlife such as bats.","J Med Virol","Chen, Yu","Liu, Qianyun","Guo, Deyin","31967327"],"abstract":["The recent emergence of a novel coronavirus (2019-nCoV), which is causing an outbreak of unusual viral pneumonia in patients in Wuhan, a central city in China, is another warning of the risk of CoVs posed to public health. In this minireview, we provide a brief introduction of the general features of CoVs and describe diseases caused by different CoVs in humans and animals. This review will help understand the biology and potential risk of CoVs that exist in richness in wildlife such as bats."],"journal":"J Med Virol","authors":["Chen, Yu","Liu, Qianyun","Guo, Deyin"],"date":"2020-01-23T11:00:00Z","year":2020,"_id":"31967327","source":"PubMed","week":"20204|Jan 20 - Jan 26","doi":"10.1002/jmv.25681","keywords":["coronavirus","epidemiology","pathogenesis","respiratory tract","virus classification","zoonoses"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism"],"weight":1,"_version_":1666138490928103425,"score":52.366856},{"pmid":32313824,"pmcid":"PMC7167492","title":"Coronavirus as silent killer: recent advancement to pathogenesis, therapeutic strategy and future perspectives.","text":["Coronavirus as silent killer: recent advancement to pathogenesis, therapeutic strategy and future perspectives.","The present outbreak associated with corona virus [CoVs] in China which is believed to be one of the massive eruptions towards mankind in 2019-2020. In the present scenario CoVs has been transmitted to the European and American regions through the travellers from wide spread countries like China and Japan. The viral disease is spreading through the contact in any form by the infected persons or patients and creating huge risk of mortality. CoVs are a single positive-sense RNA virus; mutation rates are higher than DNA viruses and indicate a more effective survival adaption mechanism. Human CoVs can cause common cold and influenza-like illness and a variety of severe acute respiratory disease such as pneumonia. Early in infection, CoVs infects epithelial cells, macrophages, T-cells, dendritic cells and also can affect the development and implantation of pro-inflammatory cytokines and chemokines. It mainly produces the melanoma differentiation associated with protein-5, retinoic acid inducible gene-1 and endosomal toll-like receptor 3. How CoVs affects the function of the immune system is still unclear due to lack of this knowledge. No Food and Drug Administration approved treatment is available till date. In this review, we are tried to explore the epidemiology, pathogenesis and current treatment of CoVs infection. The promising therapeutics molecules against CoVs and future prospective have been also discussed which will be helpful for researchers to find out the new molecules for the treatment of CoVs disease.","Virusdisease","Raj, Khadga","Rohit","Ghosh, Anirban","Singh, Shamsher","32313824"],"abstract":["The present outbreak associated with corona virus [CoVs] in China which is believed to be one of the massive eruptions towards mankind in 2019-2020. In the present scenario CoVs has been transmitted to the European and American regions through the travellers from wide spread countries like China and Japan. The viral disease is spreading through the contact in any form by the infected persons or patients and creating huge risk of mortality. CoVs are a single positive-sense RNA virus; mutation rates are higher than DNA viruses and indicate a more effective survival adaption mechanism. Human CoVs can cause common cold and influenza-like illness and a variety of severe acute respiratory disease such as pneumonia. Early in infection, CoVs infects epithelial cells, macrophages, T-cells, dendritic cells and also can affect the development and implantation of pro-inflammatory cytokines and chemokines. It mainly produces the melanoma differentiation associated with protein-5, retinoic acid inducible gene-1 and endosomal toll-like receptor 3. How CoVs affects the function of the immune system is still unclear due to lack of this knowledge. No Food and Drug Administration approved treatment is available till date. In this review, we are tried to explore the epidemiology, pathogenesis and current treatment of CoVs infection. The promising therapeutics molecules against CoVs and future prospective have been also discussed which will be helpful for researchers to find out the new molecules for the treatment of CoVs disease."],"journal":"Virusdisease","authors":["Raj, Khadga","Rohit","Ghosh, Anirban","Singh, Shamsher"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32313824","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1007/s13337-020-00580-4","keywords":["china","covs","epidemiology","pathogenesis and current treatment","vaccines"],"locations":["China","American","China","Japan"],"countries":["United States","Japan","China"],"countries_codes":["USA|United States","JPN|Japan","CHN|China"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1666138493581000704,"score":43.087414}]}